Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities

Autor: Bechten, Arianne, Wattjes, Mike P., Purcell, Derk D., Aliaga, Esther Sanchez, Daams, Marita, Brashear, H. Robert, Arrighi, H. Michael, Barkhof, Frederik

Publikováno v: Bechten, A, Wattjes, M P, Purcell, D D, Aliaga, E S, Daams, M, Brashear, H R, Arrighi, H M & Barkhof, F 2017, ' Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities ', Journal of Neuroimaging, vol. 27, no. 3, pp. 318-325 . https://doi.org/10.1111/jon.12422
Journal of Neuroimaging, 27(3), 318-325. Wiley-Blackwell

INTRODUCTION: Immunotherapeutic agents against amyloid beta (Aβ) are associated with adverse events, including amyloid-related imaging abnormalities with edema and effusion (ARIA-E). Recently, a magnetic resonance imaging (MRI) rating scale was deve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fc4913169a4c4db07e43f4c86654cc81
https://research.vumc.nl/en/publications/ce2b43b0-db4e-4a82-bfe2-68299e27f851

CSF beta-amyloid 1-42, but not CSF tau, phosphorylated tau or hippocampal atrophy on MRI relate to Alzheimer's disease pathology load in the brain

Autor: Bouwman, Femke, Schoonenboom, Niki, Vrugte, Sabine, Bechten, Arianne, Barkhof, Frederik, Rozemuller, Annemieke, Visser, Pieter Jelle, Teunissen, Charlotte, Scheltens, Philip, Van der Flier, Wiesje

Publikováno v: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2013 9(4) Supplement:P433-P433